Literature DB >> 10854736

The norbornenyl moiety of cyclothiazide determines the preference for flip-flop variants of AMPA receptor subunits.

M Kessler1, G Rogers, A Arai.   

Abstract

Cyclothiazide and two analogs in which the norbornenyl part was replaced with a cyclohexyl or a cyclohexenyl moiety were examined with regard to their preference for flop vs. flip splice variants of the (+/-)-alphaamino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor subunits GluR2, 3 and 4. The studies were carried out by measuring the effects of the drugs on the binding of [(3)H]AMPA or [(3)H]fluorowillardiine to membranes from HEK293 cells that stably express the AMPA receptor subunits. Cyclothiazide had four to nine times lower EC(50) values at flip than at flop receptors, as previously reported. In contrast, the two analogs showed little discrimination for GluR3 or GluR4 splice variants and a clear preference for the flop variant in the case of GluR2. These results indicate that it is the norbornenyl component of cyclothiazide which confers the selectivity vis-a-vis flip-flop variants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854736     DOI: 10.1016/s0304-3940(00)01180-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy.

Authors:  Jonathan E Harms; Morris Benveniste; John K F Maclean; Kathryn M Partin; Craig Jamieson
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

2.  A charge-inverting mutation in the "linker" region of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors alters agonist binding and gating kinetics independently of allosteric modulators.

Authors:  Jonathan E Harms; Morris Benveniste; Markus Kessler; Leslie M Stone; Amy C Arai; Kathryn M Partin
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

3.  Synaptic reliability and temporal precision are achieved via high quantal content and effective replenishment: auditory brainstem versus hippocampus.

Authors:  Elisa G Krächan; Alexander U Fischer; Jürgen Franke; Eckhard Friauf
Journal:  J Physiol       Date:  2016-12-02       Impact factor: 5.182

4.  Alternatively spliced three novel transcripts of gria1 in the cerebellum and cortex of mouse brain.

Authors:  Shafquat Azim; Abdul Rouf Banday; Mohammad Tabish
Journal:  Neurochem Res       Date:  2011-09-17       Impact factor: 3.996

5.  Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation.

Authors:  David E Timm; Morris Benveniste; Autumn M Weeks; Eric S Nisenbaum; Kathryn M Partin
Journal:  Mol Pharmacol       Date:  2011-05-04       Impact factor: 4.436

6.  Factors affecting guanine nucleotide binding to rat AMPA receptors.

Authors:  Kyle Montgomery; Erika Suzuki; Markus Kessler; Amy C Arai
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

7.  Mechanism of inhibition of the GluA2 AMPA receptor channel opening by talampanel and its enantiomer: the stereochemistry of the 4-methyl group on the diazepine ring of 2,3-benzodiazepine derivatives.

Authors:  Congzhou Wang; Li Niu
Journal:  ACS Chem Neurosci       Date:  2013-02-12       Impact factor: 4.418

8.  Functional insight into development of positive allosteric modulators of AMPA receptors.

Authors:  Autumn M Weeks; Jonathan E Harms; Kathryn M Partin; Morris Benveniste
Journal:  Neuropharmacology       Date:  2014-05-27       Impact factor: 5.250

Review 9.  The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

Authors:  Claire L Palmer; Lucy Cotton; Jeremy M Henley
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

10.  A Targeted Mutation Disrupting Mitochondrial Complex IV Function in Primary Afferent Neurons Leads to Pain Hypersensitivity Through P2Y1 Receptor Activation.

Authors:  Rory Mitchell; Graham Campbell; Marta Mikolajczak; Katie McGill; Don Mahad; Sue M Fleetwood-Walker
Journal:  Mol Neurobiol       Date:  2019-01-28       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.